Globus Medical to Buy NuVasive in $3 Billion All-Stock Deal

Medical device maker Globus Medical Inc. has agreed to buy smaller competitor NuVasive Inc. in an all-stock transaction valuing it at more than $3 billion.

NuVasive investors will receive 0.75 of a share of Globus Class A stock for each of their shares, according to a statement on Thursday that confirmed an earlier Bloomberg News report. The combined company will have an 11-member board consisting of eight directors from the current Globus board and three from NuVasive’s.

“This transaction reflects our mission to become the leading musculoskeletal technology company in the world by developing products that promote healing in ...